PeptiDream Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PPTDF research report →
About the company
PeptiDream Inc. is a biopharmaceutical firm dedicated to discovering and advancing innovative therapeutic solutions, including constrained peptides, small molecules, and peptide-drug conjugates. The company utilizes its exclusive Peptide Discovery Platform System (PDPS), an advanced drug discovery engine, to propel the development of its peptide-based product pipeline.
- CEO
- Patrick Crawford Reid
- IPO
- 2014
- Employees
- 621
- HQ
- Kawasaki, JP
Price Chart
- Market Cap
- $770.95M
- P/E
- -37.19
- P/S
- 6.93
- P/B
- 2.67
- EV/EBITDA
- -49.04
- Div Yield
- 0.00%
- Gross Margin
- 42.42%
- Op Margin
- -24.91%
- Net Margin
- -18.74%
- ROE
- -6.88%
- ROIC
- -4.89%
- Revenue
- $18.54B · -60.29%
- Net Income
- $-3,752,475,486 · -124.99%
- EPS
- $-29.80 · -125.72%
- Op Income
- $-4,978,820,652
- FCF YoY
- -169.05%
- 52W High
- $13.18
- 52W Low
- $5.98
- 50D MA
- $6.78
- 200D MA
- $9.43
- Beta
- 0.49
- Avg Volume
- 256
Get TickerSpark's AI analysis on PPTDF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PPTDF coverage
Recent articles, reports, and earnings notes.
No research on PPTDF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PPTDF report →Similar companies
Peers in the same neighborhood.